Background Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate. Mast cells actively participate in the pathogenesis of MS, in part because ...

While MS isn’t fatal on its own, accompanying complications can shorten life. That said, treatment can significantly decrease the chance of a shortened life span. When it comes to the outlook ...

Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

Many people who receive an initial diagnosis of relapsing-remitting MS gradually worsen over time, separate from ...

Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

Decades of subtle health changes went by without answers. When worsening disability led Roger to a multiple sclerosis (MS) ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

The following is a summary of “Effect of siponimod on retinal thickness, a marker of neurodegeneration, in participants with ...